Lunch provided at NOON ▪ Talk begins at 12:10pm
The translation of biomedical innovation bridges research and clinical practice, transforming scientific discovery into patient care. The case of cell-free DNA offers an example of rapid and ongoing translation that unsettles the boundaries of research and clinical ethics, helping us to re-think the translational pathway for genomics and the challenges and opportunities it presents for ethical frameworks and guidance.
Marsha Michie, PhD is Assistant Professor in the Institute for Health & Aging at the University of California, San Francisco, and directs the Responsible Conduct of Research course for the UCSF Clinical and Translational Science Institute. A medical anthropologist and empirical bioethicist with extensive experience in ethnography, qualitative health research, and qualitative analysis, she has focused much of her work on the experiences and decision-making of patients and research participants, specifically in the context of genetic/genomic research, technologies, and diagnoses. Professor Michie’s current research examines the translational process, from research to clinical care, for new technologies for prenatal cell-free DNA (cfDNA) screening.